Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-033416
Filing Date
2016-11-14
Accepted
2016-11-14 20:10:16
Documents
2
Period of Report
2016-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4473
2 EX-24 DOCUMENT attachment1.htm EX-24 3579
  Complete submission text file 0000899243-16-033416.txt   9473
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 5370 RUETTE DE MER SAN DIEGO CA 92130
Business Address
Ji Henry (Reporting) CIK: 0001470981 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 161997497